In 1999, we introduced rapid-acting and, in 2004, long-acting insulin analogues produced by ... we introduced the world’s first pen-shaped devices for subcutaneous injection in 1985.

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin ... form or as a disposable pen. Sanofi fights back This ...

Cipla secures CDSCO approval for Afrezza, its inhaled insulin, marking a breakthrough in diabetes management with innovative ...

Rapid-acting Fiasp (insulin aspart) is for patients to take ... which is a pre-filled, disposable pen, will fall from $559 to $140. For Tresiba’s U-100 FlexTouch, the monthly price will be ...

Insulin lispro, the rapid-acting component of Humalog Mix75/25 ... Do not reuse or share pens, needles, cartridges, or syringes between patients, even if the needle is changed.

Advantages of using insulin pens Long-acting insulin analogues offer several benefits over traditional human insulin. They provide a longer duration of action, more stable blood sugar control ...